Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

July 01, 2016; Volume 68,Issue 3

Review Articles

  • You have access
    Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research
    Paul W. Czoty, William W. Stoops and Craig R. Rush
    Michael A. Nader, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 533-562; DOI: https://doi.org/10.1124/pr.115.011668
  • Open Access
    Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
    Martin J. Brodie, Frank Besag, Alan B. Ettinger, Marco Mula, Gabriella Gobbi, Stefano Comai, Albert P. Aldenkamp and Bernhard J. Steinhoff
    David R. Sibley, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 563-602; DOI: https://doi.org/10.1124/pr.115.012021
  • You have access
    Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease
    Brice Korkmaz, Adam Lesner, Carla Guarino, Magdalena Wysocka, Christine Kellenberger, Hervé Watier, Ulrich Specks, Francis Gauthier and Dieter E. Jenne
    David R. Sibley, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 603-630; DOI: https://doi.org/10.1124/pr.115.012104
  • You have access
    Molecular Pharmacology of δ-Opioid Receptors
    Louis Gendron, Catherine M. Cahill, Mark von Zastrow, Peter W. Schiller and Graciela Pineyro
    Christie J. Macdonald, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 631-700; DOI: https://doi.org/10.1124/pr.114.008979
  • You have access
    Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
    Phatsapong Yingchoncharoen, Danuta S. Kalinowski and Des R. Richardson
    Eric L. Barker, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 701-787; DOI: https://doi.org/10.1124/pr.115.012070
  • You have access
    Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
    Peter J. Barnes
    Clive Page, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 788-815; DOI: https://doi.org/10.1124/pr.116.012518
  • You have access
    The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
    M. D. Scofield, J. A. Heinsbroek, C. D. Gipson, Y. M. Kupchik, S. Spencer, A. C. W. Smith, D. Roberts-Wolfe and P. W. Kalivas
    Jeffrey M. Witkin, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 816-871; DOI: https://doi.org/10.1124/pr.116.012484
  • Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers—A New Perspective?
    You have access
    Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers—A New Perspective?
    Lucas Treps, Lena-Christin Conradi, Ulrike Harjes and Peter Carmeliet
    Yoshihiro Ishikawa, ASSOCIATE EDITOR
    Pharmacological Reviews July 2016, 68 (3) 872-887; DOI: https://doi.org/10.1124/pr.116.012492
Back to top
PreviousNext

In this issue

Pharmacological Reviews: 68 (3)
Pharmacological Reviews
Vol. 68, Issue 3
1 Jul 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Review Articles
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics